Xilio Therapeutics, Inc. announced a private placement of 1,953,125 common shares at a price of $0.64 per share for the gross proceeds of $1,250,000 and prefunded warrants at a price of $0.6399 per prefunded warrant for the total gross proceeds of $11,300,000 on March 28, 2024. The private placement is expected to close on April 2, 2024, subject to the satisfaction of customary closing conditions.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | -5.08% | -10.40% | +103.64% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
67.54 USD | +2.40% | +3.05% | 84.14B | ||
1.12 USD | -5.08% | -10.40% | 41.34M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+103.64% | 41.34M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+46.00% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Xilio Therapeutics, Inc. announced that it expects to receive $11.3 million in funding